Division of Pathology, Research Center for Innovative Oncology, Chiba, Japan.
Cancer Sci. 2013 Apr;104(4):409-15. doi: 10.1111/cas.12099. Epub 2013 Feb 19.
Recently, an association between tumor infiltrating Forkhead box P3 regulatory T cells (Treg ) and an unfavorable prognosis has been clinically shown in some cancers, but the mechanism of Treg induction in the tumor microenvironment remains uncertain. The aims of the present study were to examine the relationship between Treg and patient outcome and to investigate whether Treg induction is influenced by the characteristics of cancer-associated fibroblasts (CAF) in lung adenocarcinoma. The numbers of Treg in both the tumor stroma and the tumor nest were counted in 200 consecutive pathological stage I lung invasive adenocarcinoma specimens. To examine whether the characteristics of CAF influence Treg induction, we selected and cultured CAF from low Treg and high Treg adenocarcinoma. The number of Treg was much higher in the stroma than in the nest (P < 0.01). Patients with high Treg had a significantly poorer prognosis than those with low Treg (overall survival: P = 0.03; recurrence-free survival: P = 0.02; 5-year overall survival: 85.4% vs 93.0%). Compared with the CAF from low Treg adenocarcinoma, culture supernatant of the CAF from high Treg adenocarcinoma induced more Treg (P = 0.01). Also, CAF from high Treg adenocarcinoma expressed significantly higher mRNA levels of transforming growth factor-β (P = 0.01) and vascular endothelial growth factor (P = 0.01), both of which are involved in Treg induction. Our studies suggest the possibility that CAF expressing immunoregulatory cytokines may induce Treg in the stroma, creating a tumor-promoting microenvironment in lung adenocarcinoma that leads to a poor outcome.
最近,一些癌症的临床研究表明,肿瘤浸润性叉头框 P3 调节性 T 细胞(Treg)与不良预后相关,但 Treg 在肿瘤微环境中的诱导机制仍不确定。本研究旨在探讨 Treg 与患者预后的关系,并研究 Treg 的诱导是否受肺癌中癌相关成纤维细胞(CAF)特征的影响。在 200 例连续的病理 I 期肺浸润性腺癌标本中,计数肿瘤基质和肿瘤巢中 Treg 的数量。为了研究 CAF 的特征是否影响 Treg 的诱导,我们从低 Treg 和高 Treg 腺癌中选择和培养 CAF。基质中 Treg 的数量明显高于巢内(P<0.01)。高 Treg 患者的总生存期(P=0.03)和无复发生存期(P=0.02)明显差于低 Treg 患者,5 年总生存率为 85.4%比 93.0%。与低 Treg 腺癌的 CAF 相比,高 Treg 腺癌 CAF 的培养上清液诱导的 Treg 更多(P=0.01)。此外,高 Treg 腺癌的 CAF 表达更高水平的转化生长因子-β(P=0.01)和血管内皮生长因子(P=0.01)mRNA,这两者都参与 Treg 的诱导。我们的研究表明,表达免疫调节细胞因子的 CAF 可能在基质中诱导 Treg,在肺腺癌中形成促进肿瘤的微环境,导致不良预后。